RFG
Invesco S&P MidCap 400 Pure Growth ETF
$55.87
-0.46
(-0.82%)
AUM
$312.67M
Expense Ratio
0.35%
NAV
$56.34
Holdings
102
Asset Class
Equity
Inception
03/01/2006
Provider
Invesco
Top Holdings
1
HALO
Halozyme Therapeutics Inc
3.36%
2
TWLO
Twilio Inc
2.34%
3
MEDP
Medpace Holdings Inc
2.17%
4
FTI
TechnipFMC PLC
2.17%
5
VAL
Valaris Ltd
2.11%
6
IDCC
InterDigital Inc
2.02%
7
ARWR
Arrowhead Pharmaceuticals Inc
1.85%
8
FIVE
Five Below Inc
1.82%
9
EXEL
Exelixis Inc
1.77%
10
CORT
Corcept Therapeutics Inc
1.77%
Fund Description
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index is composed of a subset of securities from the S&P MidCap 400® Index that exhibit strong growth characteristics.